𧬠GLP-3R FEATURES
Everything You Get With GLP-3R
Advanced metabolic research support across appetite signaling, insulin sensitivity,
lipid pathways, obesity models, and body composition outcomes.
GLP-3R comes as a stable, freeze-dried powder in a sealed vial β the gold-standard format
for
research peptides. It stays stable longer, ships safely, and gives you a clean, consistent
starting point
every time you reconstitute it. No guesswork, no degradation in transit.
Unlike most weight-loss compounds that cause muscle loss alongside fat loss, GLP-3R's
glucagon pathway selectively targets fat cells for energy. Studies show subjects retain lean
body mass β
making it a standout compound for body composition research.
GLP-3R activates both GLP-1 and GIP incretin pathways, boosting how well cells respond to
insulin. Research data shows meaningful improvements in blood sugar control. Perfect for
diabetes and
metabolic disorder research.
Most peptides only reduce hunger OR burn fat β not both. GLP-3R does both at once. The GLP-1
receptor cuts appetite; the glucagon receptor tells fat cells to burn energy. Study both
mechanisms in one
clean protocol.
Published research shows GLP-3R reduces ANGPTL3/8 β the protein responsible for raising
triglycerides and LDL cholesterol β via the glucagon receptor pathway. A powerful tool for
cardiovascular and
lipid metabolism researchers.
GLP-1 receptor activation reaches the brain directly, affecting hunger at the brain level β
not just in the stomach. GLP-3R opens CNS-metabolic crossover research that single-target
peptides simply
can't access.
Hitting all three receptors at once creates synergy β the combined effect is stronger than
the sum of each pathway individually. Preclinical models confirm GLP-3R outperforms separate
compounds given
together. One peptide, amplified results.
GLP-3R is among the most studied investigational compounds for obesity and T2D research. It
covers both calorie-reduction (appetite) and metabolic acceleration (fat burning + glucose
control) in one
compound.